Document Detail


Troponin, where do we go from here?
MedLine Citation:
PMID:  9439882     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The development of new techniques brings new challenges of interpretation and changes in previously standard clinical paradigms, but it also provides an opportunity to markedly enhance our understanding of the processes that lead to cardiovascular pathobiology. The troponins offer great promise as a method for us to further our understanding of the pathogenesis of a variety of cardiac syndromes.
Authors:
A S Jaffe
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinics in laboratory medicine     Volume:  17     ISSN:  0272-2712     ISO Abbreviation:  Clin. Lab. Med.     Publication Date:  1997 Dec 
Date Detail:
Created Date:  1998-02-13     Completed Date:  1998-02-13     Revised Date:  2006-03-28    
Medline Journal Info:
Nlm Unique ID:  8100174     Medline TA:  Clin Lab Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  737-52     Citation Subset:  IM    
Affiliation:
Cardiovascular Division, State University of New York Health Science Center at Syracuse, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers*
Cardiovascular Diseases / diagnosis
False Positive Reactions
Humans
Myocardium*
Troponin*
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Troponin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Why cardiospecificity is preeminent in myocardial markers of injury.
Next Document:  The enzyme ribonucleotide reductase: target for antitumor and anti-HIV therapy.